| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) | 
|---|
| 10/30/2014 | US20140322754 Method for highly expressing recombinant protein of engineering bacteria and use thereof | 
| 10/30/2014 | US20140322752 Refolding transforming growth factor beta family proteins | 
| 10/30/2014 | US20140322730 Botulinum Neurotoxin E Receptors and Uses Thereof | 
| 10/30/2014 | US20140322725 Sensors and assays for ubiquitin or ubiquitin-like proteins | 
| 10/30/2014 | US20140322718 Competence stimulating peptide | 
| 10/30/2014 | US20140322301 Mucin antigen vaccine | 
| 10/30/2014 | US20140322279 Self-Assembling Peptides Incorporating Modifications and Methods of Use Thereof | 
| 10/30/2014 | US20140322274 Therapeutic Agents | 
| 10/30/2014 | US20140322269 Engineered outer domain (eod) of hiv gp120 and mutants thereof | 
| 10/30/2014 | US20140322257 Fusion proteins representing different ns: proposal for a vaccine against allergy to mites | 
| 10/30/2014 | US20140322254 Polypeptide adjuvant | 
| 10/30/2014 | US20140322216 Glypican-3-specific antibody and uses thereof | 
| 10/30/2014 | US20140322212 Effective targeting of primary human leukemia using anti-cd123 chimeric antigen receptor engineered t cells | 
| 10/30/2014 | US20140322205 Rtef-1 variants and the use thereof for inhibition of angiogenesis | 
| 10/30/2014 | US20140322192 Proteoglycan degrading mutants for treatment of cns | 
| 10/30/2014 | US20140322132 Fragments of p97 and uses thereof | 
| 10/28/2014 | US8871999 Protection against herbivores | 
| 10/28/2014 | US8871931 Di-O-methylcoelenteramide and analogs thereof for production of coelenteramide and analogs thereof | 
| 10/28/2014 | US8871915 Peptides targeting TNF family receptors and antagonizing TNF action, compositions, methods and uses thereof | 
| 10/28/2014 | US8871906 Deletions in domain II of pseudomonas exotoxin a that remove immunogenic epitopes | 
| 10/28/2014 | US8871905 Modification of CXCR4 using engineered zinc finger proteins | 
| 10/28/2014 | US8871900 Fibroblast growth factor (FGF) analogs and uses thereof | 
| 10/28/2014 | US8871899 Control of viral-host membrane fusion with hydrogen bond surrogate-based artificial helices | 
| 10/28/2014 | US8871734 Transgene delivering retrovirus targeting collagen exposed at site of tissue injury | 
| 10/28/2014 | US8871724 Oligopeptidic compounds and uses thereof | 
| 10/28/2014 | US8871723 Glycan modified soluble receptors and binding protein and their use | 
| 10/28/2014 | US8871712 Somatostatin analogue formulations | 
| 10/28/2014 | US8871710 Method for inducing tissue growth, differentiation and/or regeneration by delivering a GDF-5 related precursor protein | 
| 10/28/2014 | US8871709 Synthetic chimeric proteins comprising epidermal growth factor and vitronectin | 
| 10/28/2014 | US8871708 Compositions and methods for treating AIDS or cancer by inhibiting the secretion of microparticles | 
| 10/28/2014 | US8871707 Elastin producing fibroblast formulations and methods of using the same | 
| 10/28/2014 | US8871489 Metabolic evolution of Escherichia coli strains that produce organic acids | 
| 10/28/2014 | US8871468 Synthetic genes for plant gums and other hydroxyproline-rich glycoproteins | 
| 10/28/2014 | US8871466 Method for enhancing the production yield of human papillomavirus L1 protein | 
| 10/28/2014 | US8871223 HSV-1 and HSV-2 vaccines and methods of use thereof | 
| 10/28/2014 | US8871222 Recombinant Flavivirus vaccines | 
| 10/28/2014 | US8871221 Methods of stimulating protective immunity employing Dengue viral antigens | 
| 10/28/2014 | US8871216 Multiple signaling pathways induced by hexvalent, monospecific and bispecific antibodies for enhanced toxicity to B-cell lymphomas and other diseases | 
| 10/28/2014 | US8871214 Detoxified Escherichia coli immunogens | 
| 10/28/2014 | US8871213 Prevention, treatment and diagnosis of P. gingivalis infection | 
| 10/28/2014 | US8871212 Amyloid-beta polypeptide vaccine | 
| 10/28/2014 | US8871206 Anti-human folate receptor beta antibodies and methods of use | 
| 10/28/2014 | US8871205 Methods and compositions for the treatment of immune disorders | 
| 10/28/2014 | US8871192 IL-1F8 polypeptides | 
| 10/28/2014 | US8871191 Use of IL-15 preparations to treat lymphopenia | 
| 10/23/2014 | US20140317778 Nucleic acid molecules encoding enzymes that confer disease resistance in jute | 
| 10/23/2014 | US20140316122 Hepatitis b virus vaccines | 
| 10/23/2014 | US20140316116 Methods for screening for binding partners of g-protein coupled receptors | 
| 10/23/2014 | US20140316114 Method for preparing active form of tnfr-fc fusion protein | 
| 10/23/2014 | US20140316109 Activated collagen scaffold materials and their special fused active restoration factors | 
| 10/23/2014 | US20140316106 Integrin-blocking polypeptides and uses thereof | 
| 10/23/2014 | US20140316105 Method for modification of organic molecules | 
| 10/23/2014 | US20140315987 Cholecystokinin b receptor (cckbr) mini-promoters | 
| 10/23/2014 | US20140315984 Methods and Compositions for Treatment of Diabetes and Related Disorders | 
| 10/23/2014 | US20140315825 Anti-cancer compositions containing wnt decoy receptor | 
| 10/23/2014 | US20140315824 Peptide preparations and peptides with antitumour activity | 
| 10/23/2014 | US20140315822 High mast2-affinity polypeptides and uses thereof | 
| 10/23/2014 | US20140315820 High-Potency Botulinum Toxin Formulations | 
| 10/23/2014 | US20140315819 Active small-molecule donkey-hide gelatin mixture and preparation method and application thereof | 
| 10/23/2014 | US20140315817 Variant serum albumin with improved half-life and other properties | 
| 10/23/2014 | US20140315816 Albumin variants | 
| 10/23/2014 | US20140315804 Fusion proteins comprising pdgf and vegf binding portions and methods of using thereof | 
| 10/23/2014 | US20140315802 Derivatisation of Erythropoietin (EPO) | 
| 10/23/2014 | US20140315800 Glycosylated Polypeptide and Drug Composition Containing Said Polypeptide | 
| 10/23/2014 | US20140315798 Chemically and thermodynamically stable insulin analogues and improved methods for their production | 
| 10/23/2014 | US20140315797 Novel N-Terminally Modified Insulin Derivatives | 
| 10/23/2014 | US20140315791 Method of making biologically active alpha-beta peptides | 
| 10/23/2014 | US20140315784 Binding Inhibitors of the Beta. Transducin Repeat-Containing Protein | 
| 10/23/2014 | US20140315746 Compositions and methods for the treatment of prostate carcinoma | 
| 10/23/2014 | US20140315299 Stable proteins | 
| 10/23/2014 | US20140315276 Synthesis of linear and branched polymers of polypeptides through direct conjugation | 
| 10/23/2014 | US20140315253 Activated collagen scaffold materials and their special fused active restoration factors | 
| 10/23/2014 | US20140315231 Quantification of transthyretin and its isoforms | 
| 10/23/2014 | US20140314838 Use of pituitary adenylate cyclase-activating polypeptide (pacap) and pacap analogs for treating contrast-induced nephropathy | 
| 10/23/2014 | US20140314836 Modulation of Midbody Derivatives | 
| 10/23/2014 | US20140314831 Recombinant polypeptides for membrane fusion and uses thereof | 
| 10/23/2014 | US20140314830 Bacterially formed microcin s, a new antimicrobial peptide, effective against pathogenic microorganisms, e.g. enterohemorrhagic escherichia coli (ehec) | 
| 10/23/2014 | US20140314816 Stabilized stat3 decoy oligonucleotides and uses therefore | 
| 10/23/2014 | US20140314802 Novel compositions and methods | 
| 10/23/2014 | US20140314801 Vaccines and methods to treat lyme disease in dogs | 
| 10/23/2014 | US20140314797 Yeast strain for the production of proteins with terminal alpha-1,3-linked galactose | 
| 10/23/2014 | US20140314796 Marker for neuromyelitis optica | 
| 10/23/2014 | US20140314772 Anti-c5a binding moieties with high blocking activity | 
| 10/23/2014 | US20140314770 Kidney disease targets and uses thereof | 
| 10/23/2014 | US20140314768 Methods and compositions for treating and diagnosing diseases | 
| 10/23/2014 | US20140314761 Polypeptides having antiviral activity and methods for use thereof | 
| 10/23/2014 | US20140314760 Serine protease molecules and therapies | 
| 10/23/2014 | US20140314759 Isolated nucleotide sequences encoding gdf traps | 
| 10/23/2014 | US20140314712 Fusion protein comprising an interleukin 4 and interleukin | 
| 10/23/2014 | US20140314711 IL-22 POLYPEPTIDES AND IL-22 Fc FUSION PROTEINS AND METHODS OF USE | 
| 10/23/2014 | US20140314709 Il-2 derivatives polypeptides with agonist activity for therapy of cancer and chronic infections | 
| 10/21/2014 | US8865968 Method for down-regulating gene expression in fungi | 
| 10/21/2014 | US8865967 Defensin variants and methods of use | 
| 10/21/2014 | US8865880 Identification of a novel BHD gene | 
| 10/21/2014 | US8865876 Engineered lectin oligomers with antiviral activity | 
| 10/21/2014 | US8865869 Collagen and fibrin microthreads in a discrete thread model of in vitro ACL scaffold regeneration | 
| 10/21/2014 | US8865868 Conjugated proteins with prolonged in vivo efficacy | 
| 10/21/2014 | US8865867 Lectins and uses thereof | 
| 10/21/2014 | US8865866 Diphtheria toxin variant | 
| 10/21/2014 | US8865864 Mutant epidermal growth factor polypeptides with improved biological activity and methods of their making and use |